50 results on '"Aragones, Julian"'
Search Results
2. IL-18-induced HIF-1α in ILC3s ameliorates the inflammation of C. rodentium-induced colitis
3. Erythroid SLC7A5/SLC3A2 amino acid carrier controls red blood cell size and maturation
4. The relevance of EGFR, ErbB receptors and neuregulins in human adipocytes and adipose tissue in obesity
5. Metformin reduces macrophage HIF1α-dependent proinflammatory signaling to restore brown adipocyte function in vitro
6. Role of the HIF oxygen sensing pathway in cell defense and proliferation through the control of amino acid metabolism
7. Targeting L-type amino acid transporter 1 in innate and adaptive T cells efficiently controls skin inflammation
8. Myocardial VHL-HIF Signaling Controls an Embryonic Metabolic Switch Essential for Cardiac Maturation
9. Erythropoietin receptor regulates tumor mitochondrial biogenesis through iNOS and pAKT
10. HIF2α Acts as an mTORC1 Activator through the Amino Acid Carrier SLC7A5
11. Erythropoietin receptor regulates tumor mitochondrial biogenesis through iNOS and pAKT
12. Induction of the Mitochondrial NDUFA4L2 Protein by HIF-1α Decreases Oxygen Consumption by Inhibiting Complex I Activity
13. Erythropoietin receptor regulates tumor mitochondrial biogenesis through iNOS and pAKT
14. Loss or Silencing of the PHD1 Prolyl Hydroxylase Protects Livers of Mice Against Ischemia/Reperfusion Injury
15. From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on “New frontiers in cardiovascular research”
16. Novel antibodies directed against the human erythropoietin receptor: creating a basis for clinical implementation
17. Oxygen Sensors at the Crossroad of Metabolism
18. Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization
19. Meeting report from the 2nd International Symposium on New Frontiers in Cardiovascular Research. Protecting the cardiovascular system from ischemia: between bench and bedside
20. HIF1α Suppresses Tumor Cell Proliferation through Inhibition of Aspartate Biosynthesis
21. LAT-1 and GLUT-1 Carrier Expression and Its Prognostic Value in Gastroenteropancreatic Neuroendocrine Tumors
22. Activation of HIF-prolyl Hydroxylases by R59949, an Inhibitor of the Diacylglycerol Kinase
23. Genetic evidence for a tumor suppressor role of HIF-2α
24. Inhibition of Hypoxia Inducible Factor Hydroxylases Protects Against Renal Ischemia-Reperfusion Injury
25. Role of Iron (II)-2-Oxoglutarate-dependent Dioxygenases in the Generation of Hypoxia-induced Phosphatidic Acid through HIF-1/2 and von Hippel-Lindau-independent Mechanisms
26. Role of diacylglycerol induced by hypoxia in the regulation of HIF-1α activity
27. Lack of Evidence for the Involvement of the Phosphoinositide 3-Kinase/Akt Pathway in the Activation of Hypoxia-inducible Factors by Low Oxygen Tension
28. Evidence for the Involvement of Diacylglycerol Kinase in the Activation of Hypoxia-inducible Transcription Factor 1 by Low Oxygen Tension
29. Hypoxia-Inducible Factor 2-Dependent Pathways Driving Von Hippel-Lindau-Deficient Renal Cancer
30. Up-regulation of vascular endothelial growth factor receptor Flt-1 after endothelial denudation: role of transcription factor Egr-1
31. Hypoxia-Inducible Factor 2-Dependent Pathways Driving Von Hippel–Lindau-Deficient Renal Cancer
32. FRI-298-Hypoxia-inducible factor 2 alpha drives lipid accumulation in human hepatocytes through the fatty acid translocase CD36
33. Novel antibodies directed against the human erythropoietin receptor: creating a basis for clinical implementation
34. Matrix-binding vascular endothelial growth factor (VEGF) isoforms guide granule cell migration in the cerebellum via VEGF receptor Flk1.
35. Matrix-binding vascular endothelial growth factor (VEGF) isoforms guide granule cell migration in the cerebellum via VEGF receptor Flk1.
36. Abnormal sympathoadrenal development and systemic hypotension in PHD3-/- mice
37. Sensitive and Specific Antibody Probes Directed Against The Erythropoietin Receptor – From Basic Studies To Clinical Implementation
38. Abstract 3538: The HIF-1α hypoxia response in mouse tumor-infiltrating T lymphocytes induces functional CD137 (4-1BB) for immunotherapy
39. Myeloid Hypoxia-Inducible Factors in Inflammatory Diseases
40. Matrix-Binding Vascular Endothelial Growth Factor (VEGF) Isoforms Guide Granule Cell Migration in the Cerebellum via VEGF Receptor Flk1
41. Abnormal Sympathoadrenal Development and Systemic Hypotension in PHD3−/− Mice
42. Meeting report from the 2nd International Symposium on New Frontiers in Cardiovascular Research. Protecting the cardiovascular system from ischemia: between bench and bedside.
43. Matrix-Binding Vascular Endothelial Growth Factor (VEGF) Isoforms Guide Granule Cell Migration in the Cerebellum via VEGF Receptor Flk1.
44. 61. Functional consequences of genotypic differences studied by high-resolution respirometry in small samples of permeabilized skeletal muscle fibers
45. Meeting report from the 2nd International Symposium on New Frontiers in Cardiovascular Research. Protecting the cardiovascular system from ischemia: between bench and bedside
46. From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on 'New frontiers in cardiovascular research'
47. Abnormal Sympathoadrenal Development and Systemic Hypotension in PHD3-/- Mice.
48. Dithiocarbamates Trigger Differentiation and Induction of CD11c Gene through AP-1 in the Myeloid Lineage
49. Matrix-binding vascular endothelial growth factor (VEGF) isoforms guide granule cell migration in the cerebellum via VEGF receptor Flk1
50. Specific oncolytic effect of a new hypoxia-inducible factor-dependent replicative adenovirus on von Hippel-Lindau-defective renal cell carcinomas.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.